Drug establishmentActive, Registered FY2026FDA warning letter on file
BIOASIA WORLDWIDE SDN. BHD.
BIOASIA WORLDWIDE SDN. BHD. is an FDA-registered drug establishment (FEI 3015509166) located in . The facility is active, registered for FY2026. Its most recent FDA inspection on record (2024-10-17) was classified OAI. FDA has issued 1 warning letter(s) to this facility.
FDA warning letter
A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.
Establishment record
Inspection history
Questions
Is BIOASIA WORLDWIDE SDN. BHD. registered with the FDA?
Yes. BIOASIA WORLDWIDE SDN. BHD. is an FDA-registered drug establishment (FEI 3015509166) in . Its current registration status is Active, Registered FY2026.
Has BIOASIA WORLDWIDE SDN. BHD. received an FDA warning letter?
Yes. FDA issued a warning letter to BIOASIA WORLDWIDE SDN. BHD.; the most recent is dated Mar 25, 2025 (CGMP/Finished Pharmaceuticals/Adulterated).
What does BIOASIA WORLDWIDE SDN. BHD. do?
BIOASIA WORLDWIDE SDN. BHD.'s FDA-registered operations are: Manufacturing.
Related facilities
Source: FDA public data · status as of 2026-06-06